Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt No Debt
PDII's Cash to Debt is ranked higher than
94% of the 974 Companies
in the Global Business Services industry.

( Industry Median: 1.01 vs. PDII: No Debt )
PDII' s 10-Year Cash to Debt Range
Min: 58   Max: No Debt
Current: No Debt

Equity to Asset 0.41
PDII's Equity to Asset is ranked higher than
58% of the 944 Companies
in the Global Business Services industry.

( Industry Median: 0.46 vs. PDII: 0.41 )
PDII' s 10-Year Equity to Asset Range
Min: -0.09   Max: 0.81
Current: 0.41

-0.09
0.81
Interest Coverage No Debt
PDII's Interest Coverage is ranked higher than
84% of the 666 Companies
in the Global Business Services industry.

( Industry Median: 25.65 vs. PDII: No Debt )
PDII' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 4
Z-Score: 0.02
M-Score: -0.71
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -9.13
PDII's Operating margin (%) is ranked lower than
58% of the 968 Companies
in the Global Business Services industry.

( Industry Median: 6.26 vs. PDII: -9.13 )
PDII' s 10-Year Operating margin (%) Range
Min: -43.69   Max: 9.86
Current: -9.13

-43.69
9.86
Net-margin (%) -9.44
PDII's Net-margin (%) is ranked lower than
58% of the 968 Companies
in the Global Business Services industry.

( Industry Median: 4.08 vs. PDII: -9.44 )
PDII' s 10-Year Net-margin (%) Range
Min: -41.75   Max: 8.21
Current: -9.44

-41.75
8.21
ROE (%) -39.69
PDII's ROE (%) is ranked lower than
61% of the 928 Companies
in the Global Business Services industry.

( Industry Median: 9.05 vs. PDII: -39.69 )
PDII' s 10-Year ROE (%) Range
Min: -53.65   Max: 39.76
Current: -39.69

-53.65
39.76
ROA (%) -18.63
PDII's ROA (%) is ranked lower than
60% of the 980 Companies
in the Global Business Services industry.

( Industry Median: 3.98 vs. PDII: -18.63 )
PDII' s 10-Year ROA (%) Range
Min: -26.61   Max: 21.83
Current: -18.63

-26.61
21.83
ROC (Joel Greenblatt) (%) -409.05
PDII's ROC (Joel Greenblatt) (%) is ranked lower than
62% of the 972 Companies
in the Global Business Services industry.

( Industry Median: 28.23 vs. PDII: -409.05 )
PDII' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1034.1   Max: 600
Current: -409.05

-1034.1
600
Revenue Growth (3Y)(%) 2.90
PDII's Revenue Growth (3Y)(%) is ranked higher than
64% of the 817 Companies
in the Global Business Services industry.

( Industry Median: 4.50 vs. PDII: 2.90 )
PDII' s 10-Year Revenue Growth (3Y)(%) Range
Min: -30.9   Max: 64.7
Current: 2.9

-30.9
64.7
EBITDA Growth (3Y)(%) -18.40
PDII's EBITDA Growth (3Y)(%) is ranked lower than
51% of the 691 Companies
in the Global Business Services industry.

( Industry Median: 6.30 vs. PDII: -18.40 )
PDII' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -63.3   Max: 107.3
Current: -18.4

-63.3
107.3
EPS Growth (3Y)(%) -14.70
PDII's EPS Growth (3Y)(%) is ranked higher than
52% of the 620 Companies
in the Global Business Services industry.

( Industry Median: 7.30 vs. PDII: -14.70 )
PDII' s 10-Year EPS Growth (3Y)(%) Range
Min: -52.5   Max: 44.9
Current: -14.7

-52.5
44.9
» PDII's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

PDII Guru Trades in Q4 2013

Jim Simons 530,900 sh (+0.26%)
Chuck Royce 885,122 sh (unchged)
» More
Q1 2014

PDII Guru Trades in Q1 2014

Chuck Royce 885,122 sh (unchged)
Jim Simons 525,700 sh (-0.98%)
» More
Q2 2014

PDII Guru Trades in Q2 2014

Jim Simons 530,900 sh (+0.99%)
Chuck Royce 810,622 sh (-8.42%)
» More
Q3 2014

PDII Guru Trades in Q3 2014

Jim Simons 547,600 sh (+3.15%)
Chuck Royce 630,848 sh (-22.18%)
» More
» Details

Insider Trades

Latest Guru Trades with PDII

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Charles Brandes 2013-09-30 Sold Out $4.3 - $5.25 $ 1.53-68%0
Charles Brandes 2013-06-30 New Buy$4.04 - $5.74 $ 1.53-66%10800
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.92
PDII's P/B is ranked higher than
88% of the 1121 Companies
in the Global Business Services industry.

( Industry Median: 3.32 vs. PDII: 0.92 )
PDII' s 10-Year P/B Range
Min: 0.41   Max: 3.36
Current: 0.92

0.41
3.36
P/S 0.17
PDII's P/S is ranked higher than
97% of the 1121 Companies
in the Global Business Services industry.

( Industry Median: 1.76 vs. PDII: 0.17 )
PDII' s 10-Year P/S Range
Min: 0.17   Max: 1.43
Current: 0.17

0.17
1.43
EV-to-EBIT 0.30
PDII's EV-to-EBIT is ranked higher than
99% of the 1121 Companies
in the Global Business Services industry.

( Industry Median: 19.22 vs. PDII: 0.30 )
PDII' s 10-Year EV-to-EBIT Range
Min: -49.9   Max: 14.8
Current: 0.3

-49.9
14.8
Current Ratio 1.47
PDII's Current Ratio is ranked higher than
65% of the 963 Companies
in the Global Business Services industry.

( Industry Median: 1.43 vs. PDII: 1.47 )
PDII' s 10-Year Current Ratio Range
Min: 0.88   Max: 6.06
Current: 1.47

0.88
6.06
Quick Ratio 1.47
PDII's Quick Ratio is ranked higher than
69% of the 963 Companies
in the Global Business Services industry.

( Industry Median: 1.31 vs. PDII: 1.47 )
PDII' s 10-Year Quick Ratio Range
Min: 0.88   Max: 6.06
Current: 1.47

0.88
6.06

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.51
PDII's Price/Tangible Book is ranked higher than
79% of the 1121 Companies
in the Global Business Services industry.

( Industry Median: 15.63 vs. PDII: 2.51 )
PDII' s 10-Year Price/Tangible Book Range
Min: 0.46   Max: 10.52
Current: 2.51

0.46
10.52
Price/Median PS Value 0.24
PDII's Price/Median PS Value is ranked higher than
99% of the 1121 Companies
in the Global Business Services industry.

( Industry Median: 1.20 vs. PDII: 0.24 )
PDII' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 4.82
Current: 0.24

0.18
4.82
Earnings Yield (Greenblatt) 333.30
PDII's Earnings Yield (Greenblatt) is ranked higher than
99% of the 968 Companies
in the Global Business Services industry.

( Industry Median: 5.90 vs. PDII: 333.30 )
PDII' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.7   Max: 33126.9
Current: 333.3

6.7
33126.9

Business Description

Industry: Business Services » Business Services
Compare:ADP, G, ENV, CMPGY, SGSOY » details
Traded in other countries:PF4.Germany,
PDI Inc was incorporated in Delaware just prior to its initial public offering in May 1998. The Company is a provider of outsourced commercial services to pharmaceutical, biotechnology and healthcare companies in the United States. It is a provider of outsourced sales teams that target healthcare providers, offering a range of complementary sales support services. The Company operates in three segments: Sales Services, Marketing Services and Product Commercialization segment. Sales Services segment focuses primarily on product detailing, and includes its outsourced sales teams and EngageCE business unit. Product detailing involves a sales representative meeting face-to-face with targeted physicians and other healthcare decision makers to provide a technical review of the product being promoted and deliver marketing materials, including samples. Marketing Services segment includes two business units: Group DCA; and PDI Voice (Voice). Group DCA's business is focused on the creation, design and implementation of interactive digital communications, including its e-detailing programs to the healthcare community on behalf of its pharmaceutical, biotechnology and healthcare customers. Voice's business is focused on the creation of teledetailing programs that are executed via tele-representatives. Product Commercialization Services segment includes its efforts related to its two collaboration agreements entered into to become a commercialization company for the molecular diagnostics industry through its Interpace Diagnostics entity; and its Interpace BioPharma business unit.
» More Articles for PDII

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: PDI Inc, RCS Capital Corp, Providence Service Corp. Nov 30 2014 
Six Sells in Review - The Charles Brandes Third Quarter Update Nov 14 2013 
Six Royce Reductions in Third Quarter Oct 09 2013 
PDI Inc. Reports Operating Results (10-Q) Aug 04 2010 
PDI Inc. Reports Operating Results (10-Q) May 06 2010 
PDI Inc. Reports Operating Results (10-Q) Nov 05 2009 
PDI Inc. (PDII) CEO Nancy Lurker buys 9,960 Shares Aug 18 2009 
PDI Inc. Reports Operating Results (10-Q) May 08 2009 
Weekly highlight of CFO buys: W.R. Grace & Co. (GRA), PDI Inc. (PDII), Brandywine Realty Trust (BDN) Dec 07 2008 

More From Other Websites
PDI, Inc. Subsidiary Interpace Diagnostics Announces Launch of ThyGenX™ Next-Generation Sequencing... Dec 17 2014
PDI, Inc. Subsidiary Interpace Diagnostics Announces Launch of ThyGenX™ Next-Generation Sequencing... Dec 17 2014
Insider Trading Alert - PDII, SSI And FBIZ Traded By Insiders Nov 26 2014
PDI INC Financials Nov 19 2014
PDI INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 19 2014
10-Q for PDI, Inc. Nov 07 2014
PDI INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 05 2014
PDI INC Files SEC form 10-Q, Quarterly Report Nov 05 2014
PDI INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and... Nov 03 2014
PDI Inc Earnings Call scheduled for 8:00 am ET today Nov 03 2014
Q3 2014 PDI Inc Earnings Release - Time Not Supplied Nov 03 2014
PDI Expands Molecular Diagnostics Business with RedPath Integrated Pathology Acquisition Nov 03 2014
PDI Reports 2014 Third Quarter Financial Results; Acquires RedPath Integrated Pathology Nov 03 2014
PDI Reports 2014 Third Quarter Financial Results; Acquires RedPath Integrated Pathology Nov 03 2014
PDI Expands Molecular Diagnostics Business with RedPath Integrated Pathology Acquisition Nov 03 2014
PDI, Inc. Announces Date & Time Change for Third Quarter Financial Results Conference Call Oct 31 2014
Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To... Oct 31 2014
PDI, Inc. Announces Date & Time Change for Third Quarter Financial Results Conference Call Oct 31 2014
Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To... Oct 31 2014
PDI INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Oct 30 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK